Evidence map›Paper›PMID 41896928›Full record

ArticleCancer cell international2026

Proteomic remodeling during tumor cell-induced platelet aggregation unveils metastatic drivers in colorectal cancer.

Thorben Sauer, Caroline Gruner, Katharina Kern, Antje Rackisch, Lea Tischner, Katharina Schulz, Jasmin Ostermann, Lena Cohrs, Michael Kohl, Admar Verschoor and 1 more

Abstract read
In one paragraph

Article in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Thorben SauerDepartment of Surgery, Laboratory for Surgical Research, University Hospital Schleswig-Holstein, Lübeck, Germany.ORCID http://orcid.org/0000-0002-4511-6037
Caroline GrunerDepartment of Surgery, Laboratory for Surgical Research, University Hospital Schleswig-Holstein, Lübeck, Germany.ORCID http://orcid.org/0000-0003-4596-4455
Katharina KernDepartment of Surgery, Laboratory for Surgical Research, University Hospital Schleswig-Holstein, Lübeck, Germany.
Antje RackischDepartment of Surgery, Laboratory for Surgical Research, University Hospital Schleswig-Holstein, Lübeck, Germany.
Lea TischnerDepartment of Surgery, Laboratory for Surgical Research, University Hospital Schleswig-Holstein, Lübeck, Germany.
Katharina SchulzDepartment of Surgery, Laboratory for Surgical Research, University Hospital Schleswig-Holstein, Lübeck, Germany.
Jasmin OstermannDepartment of Surgery, Laboratory for Surgical Research, University Hospital Schleswig-Holstein, Lübeck, Germany.
Lena CohrsDepartment of Oral and Cranio-Maxillofacial Surgery, University Hospital Schleswig-Holstein, Lübeck, Germany.
Michael KohlDepartment of Surgery, Laboratory for Surgical Research, University Hospital Schleswig-Holstein, Lübeck, Germany.
Admar VerschoorDepartment of Otorhinolaryngology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-5257-3033
Timo GemollDepartment of Surgery, Laboratory for Surgical Research, University Hospital Schleswig-Holstein, Lübeck, Germany. Timo.Gemoll@uni-luebeck.de.ORCID http://orcid.org/0000-0001-7400-5240

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is frequently associated with metastasis, resulting in high mortality rates. Platelets are known to play a crucial role in the metastatic cascade influencing tumor microenvironment remodeling, promoting cell transformation, facilitating metastatic niche formation, and shielding circulating tumor cells from immune surveillance. However, platelet proteomic alterations during tumor cell-induced platelet aggregation (TCIPA) remain largely unexplored. This study aims to characterize the proteomic profile of TCIPA in CRC using an in vitro model that recapitulates key aspects of CRC metastasis.

methodsTCIPA was assessed via light transmission aggregometry using an in vitro model incorporating paired primary and metastatic cell cultures. Stable Isotope Labeling with Amino Acids in Cell culture (SILAC) allowed for the discrimination of healthy platelet and tumor cell proteomes prior to and following TCIPA. Data-independent acquisition mass spectrometry was employed to analyze intra- and extracellular tumor and platelet proteomes. Comparative proteomic profiling was performed using a range of bioinformatic analyses, including clustering, differential expression, and Gene Set Enrichment Analyses (GSEA).

resultsComparison of the baseline proteome profiles of the CRC cell lines SW480 and SW620 identified 263 significant differentially abundant proteins (FDR ≤ 0.05, log2FC ≥ 1). The GSEA demonstrated enrichment of the ‘epithelial-mesenchymal transition’ (FDR: 5.617 × 10− 5) gene set in SW480 cells. While SW480 exhibited rapid TCIPA, SW620 did not consistently interact with healthy platelets. Following TCIPA, 34 tumor proteins showed differential expression compared to their naïve status (without platelet-exposure). Notably, 17 of these proteins were significantly associated with CRC progression, particularly in the promotion of EMT, metastasis, tumor cell survival, proliferation, and metabolic reprogramming.

conclusionsThis study successfully characterized the proteomic profiles of platelets, platelet secretomes, and colorectal tumor cells following TCIPA-induced activation. The findings highlight the significant role of several tumor proteins and their metabolic effects in colorectal cancer progression, particularly with regard to metastasis.

Indexed as

Colorectal cancerDIA-MSEMTMetastasisPlateletsProteomicsTCIPA

Identifiers

PMID41896928
PMCPMC13123001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.